Skip to content
← Study library

NCT05959564 · REGISTRY CONDITION SEARCH

A Chatbot Intervention for Reducing HPV Vaccine Hesitancy

Found through the registry condition index, not selected as a treatment recommendation. This discovery collection was restricted to studies with posted results.

Phase
NA
Status at capture
COMPLETED
Registry last update
2024-10-21

The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.

Open the original ClinicalTrials.gov record → · Download preserved record

What did the study report?

Outcomes, safety and baseline populations are separate source sections. Quality-of-life measures appear under their original outcome titles.

Who could take part
eligibility Criteria
Inclusion Criteria: * 18 years or older * Self-identify as Black or African American * Parents of children under 18 years old * Access to computer/laptop/mobile device and the Internet Exclusion Criteria: * Under 18 years * Does not self-identify as Black or African American * Not a parent of at least a child under 18 years old * No access to computer/laptop/mobile device or the Internet
healthy Volunteers
true
minimum Age
18 Years
sex
ALL
std Ages
  1. ADULT
  2. OLDER_ADULT
Treatment arms and interventions
arm Groups
  1. description
    After reading a standard CDC HPV vaccine message, participants will interact with a chatbot designed to deliver personalized HPV vaccine messages (i.e., tailored to their personalities).
    intervention Names
    1. Behavioral: Personalized Chatbot Intervention
    label
    Personalized Chatbot Condition
    type
    EXPERIMENTAL
  2. description
    After reading a standard CDC HPV vaccine message, participants will interact with a chatbot designed to deliver HPV vaccine messages, which are not tailored to their personalities.
    intervention Names
    1. Behavioral: Non-Personalized Chatbot Intervention
    label
    Non-Personalized Chatbot Condition
    type
    EXPERIMENTAL
  3. description
    Participants will read a standard CDC HPV vaccine message without interacting with any chatbot that delivers additional messages.
    intervention Names
    1. Behavioral: No Chatbot Control
    label
    No Chatbot Control Condition
    type
    ACTIVE_COMPARATOR
interventions
  1. arm Group Labels
    1. Personalized Chatbot Condition
    description
    In this intervention, participants will first see a standard CDC HPV vaccine message. After that they will be invited to interact with a chatbot designed to deliver additional HPV vaccine messages, which are tailored to their personalities.
    name
    Personalized Chatbot Intervention
    type
    BEHAVIORAL
  2. arm Group Labels
    1. Non-Personalized Chatbot Condition
    description
    In this intervention, participants will first see a standard CDC HPV vaccine message. After that they will be invited to interact with a chatbot designed to deliver additional HPV vaccine messages, which are not tailored to their personalities.
    name
    Non-Personalized Chatbot Intervention
    type
    BEHAVIORAL
  3. arm Group Labels
    1. No Chatbot Control Condition
    description
    In this intervention, participants will see a standard CDC HPV vaccine message only and will not interact with any chatbot.
    name
    No Chatbot Control
    type
    BEHAVIORAL
Study design
allocation
RANDOMIZED
intervention Model
PARALLEL
masking Info
masking
SINGLE
who Masked
  1. PARTICIPANT
primary Purpose
PREVENTION
Enrollment
count
456
type
ACTUAL
Registered outcome plans (not posted results)
primary Outcomes
  1. description
    Participants' attitudes toward HPV vaccination were measured by seven questions such as "The HPV vaccine is beneficial for adolescents." The responses were recorded on 1 (strongly disagree) to 5 (strongly agree) scales. Final score was the average of all 7 questions.
    measure
    Attitudes Toward HPV Vaccination
    time Frame
    baseline posttest (test took approximately 5 minutes to complete)
  2. description
    Participants' intentions toward vaccinating their children against HPV were measured by three questions such as "I am likely to get my child/children the HPV vaccine." Responses were indicated on 1 (strongly disagree) to 5 (strongly agree) scales. The final score was the average of the three questions.
    measure
    Intentions Toward HPV Vaccination
    time Frame
    baseline posttest (test took approximately 5 minutes to complete)
secondary Outcomes
  1. description
    Ratings of the Chatbot were measured by nine questions such as "How would you describe the HPV chatbot you just interacted with? - Engaging" on 1 (strongly disagree) to 5 (strongly agree) scales. The final score was the average of the nine questions.
    measure
    Ratings of the Chatbot
    time Frame
    baseline posttest (test took approximately 5 minutes to complete)
Full study description
brief Summary
The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online experiment will be conducted to test the effectiveness of the chatbot intervention with African American parents. Results of this project will inform future communication interventions for reducing vaccine hesitancy among African American parents.
detailed Description
The goal of this project is to test the efficacy of a chatbot intervention for reducing HPV vaccine hesitancy among African American parents. An online survey-experiment will be conducted. In the survey-experiment, participants will first answer questions related to their attitudes toward childhood vaccines and see a brief CDC message about HPV vaccine. Then they will be directed to interact with a chatbot designed to deliver personalized HPV vaccine messages (tailored to the participant's personality) or a similar chatbot with non-personalized messages. There will also be a control condition where participants will see the brief CDC message about HPV vaccine but will not interact with any chatbot. All participants will answer questions related to their attitudes toward HPV vaccination, intentions to vaccinate their children, as well as other message response measures.
Source references
Source notices and limitations
    Discovery and provenance
    1. release id
      ctgov-registry-1336d216cbd1bbff780dac70
      edge id
      nct-edge-e355043bacfcfd741dc2
      requested nct id
      NCT05959564
      primary nct id
      NCT05959564
      source kind
      ctgov_condition_query
      source record id
      Source null
      source file sha256
      e9517ade36d469a7fd2e8b9c24ac926bac342fd6e763013a79e66e2d510f9bb7
      payload sha256
      7b00c851252927bdd3d29177334dc9a69c8b48fe14bb4a961fddf19583ae42b8
      payload
      clinical indication matching status
      condition_index_match_asserted_by_registry_not_reviewed
      end exclusive
      true
      id
      nct-edge-e355043bacfcfd741dc2
      link basis
      returned_by_explicit_condition_and_posted_results_filter_query
      nct id
      NCT05959564
      occurrences
      1. context exact
        NCT05959564
        end
        11
        exact text
        NCT05959564
        start
        0
      offset unit
      unicode_code_points
      query cond
      Penile Cancer
      query disease state id
      ds-penile-cancer
      source file
      /Users/arunverma/Documents/ChatGPT/Cancer Statistics Website/research-data/2026-09-10/clinicaltrials-condition/round-0000/raw/cond-penile-cancer-000.json
      source file sha256
      e9517ade36d469a7fd2e8b9c24ac926bac342fd6e763013a79e66e2d510f9bb7
      source json pointer
      /studies/11/protocolSection/identificationModule/nctId
      source kind
      ctgov_condition_query
      source record id
      Source null
      source string basis
      parsed_JSON_string_unmodified
      source string sha256
      2dde9805ec1bc929bffbe37c30b6e3eed1e7616599aad7ab5b33819ff5e0ea46

    Preserved source evidence · Not medical advice